nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP3A4—Topotecan—ovarian cancer	0.083	0.272	CbGbCtD
Alosetron—CYP2C9—Paclitaxel—ovarian cancer	0.0707	0.232	CbGbCtD
Alosetron—CYP3A4—Vinorelbine—ovarian cancer	0.0585	0.192	CbGbCtD
Alosetron—CYP3A4—Paclitaxel—ovarian cancer	0.0411	0.135	CbGbCtD
Alosetron—CYP3A4—Docetaxel—ovarian cancer	0.0297	0.0973	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—ovarian cancer	0.0222	0.0726	CbGbCtD
Alosetron—Infection—Chlorambucil—ovarian cancer	0.00229	0.0033	CcSEcCtD
Alosetron—Malaise—Topotecan—ovarian cancer	0.00227	0.00327	CcSEcCtD
Alosetron—Fungal infection—Doxorubicin—ovarian cancer	0.00227	0.00327	CcSEcCtD
Alosetron—Arrhythmia—Vinorelbine—ovarian cancer	0.00221	0.00318	CcSEcCtD
Alosetron—Abdominal pain upper—Paclitaxel—ovarian cancer	0.0022	0.00316	CcSEcCtD
Alosetron—Cough—Topotecan—ovarian cancer	0.0022	0.00316	CcSEcCtD
Alosetron—Alopecia—Vinorelbine—ovarian cancer	0.00219	0.00315	CcSEcCtD
Alosetron—Cramp muscle—Paclitaxel—ovarian cancer	0.00217	0.00312	CcSEcCtD
Alosetron—Cough—Melphalan—ovarian cancer	0.00215	0.0031	CcSEcCtD
Alosetron—Nasopharyngitis—Paclitaxel—ovarian cancer	0.00215	0.0031	CcSEcCtD
Alosetron—Myalgia—Topotecan—ovarian cancer	0.00214	0.00309	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.00212	0.00306	CcSEcCtD
Alosetron—Discomfort—Topotecan—ovarian cancer	0.00212	0.00305	CcSEcCtD
Alosetron—Myalgia—Melphalan—ovarian cancer	0.0021	0.00302	CcSEcCtD
Alosetron—Abdominal distension—Paclitaxel—ovarian cancer	0.00209	0.00301	CcSEcCtD
Alosetron—Infection—Topotecan—ovarian cancer	0.00204	0.00294	CcSEcCtD
Alosetron—Ulcer—Epirubicin—ovarian cancer	0.002	0.00288	CcSEcCtD
Alosetron—Infection—Melphalan—ovarian cancer	0.002	0.00288	CcSEcCtD
Alosetron—Ill-defined disorder—Vinorelbine—ovarian cancer	0.002	0.00288	CcSEcCtD
Alosetron—Skin disorder—Topotecan—ovarian cancer	0.002	0.00287	CcSEcCtD
Alosetron—Fatigue—Chlorambucil—ovarian cancer	0.00199	0.00287	CcSEcCtD
Alosetron—Hyperhidrosis—Topotecan—ovarian cancer	0.00199	0.00286	CcSEcCtD
Alosetron—Bone pain—Epirubicin—ovarian cancer	0.00198	0.00285	CcSEcCtD
Alosetron—Pain—Chlorambucil—ovarian cancer	0.00197	0.00284	CcSEcCtD
Alosetron—Skin disorder—Melphalan—ovarian cancer	0.00196	0.00281	CcSEcCtD
Alosetron—Malaise—Vinorelbine—ovarian cancer	0.00194	0.0028	CcSEcCtD
Alosetron—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.00193	0.00278	CcSEcCtD
Alosetron—Pollakiuria—Paclitaxel—ovarian cancer	0.00192	0.00277	CcSEcCtD
Alosetron—Feeling abnormal—Chlorambucil—ovarian cancer	0.0019	0.00274	CcSEcCtD
Alosetron—Cough—Vinorelbine—ovarian cancer	0.00188	0.00271	CcSEcCtD
Alosetron—Hyperglycaemia—Paclitaxel—ovarian cancer	0.00188	0.0027	CcSEcCtD
Alosetron—Abnormal dreams—Epirubicin—ovarian cancer	0.00187	0.0027	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00187	0.0027	CcSEcCtD
Alosetron—Abdominal pain upper—Docetaxel—ovarian cancer	0.00186	0.00268	CcSEcCtD
Alosetron—Hypertension—Vinorelbine—ovarian cancer	0.00186	0.00268	CcSEcCtD
Alosetron—Ulcer—Doxorubicin—ovarian cancer	0.00185	0.00267	CcSEcCtD
Alosetron—Cystitis noninfective—Epirubicin—ovarian cancer	0.00185	0.00267	CcSEcCtD
Alosetron—Depression—Paclitaxel—ovarian cancer	0.00185	0.00266	CcSEcCtD
Alosetron—Cramp muscle—Docetaxel—ovarian cancer	0.00184	0.00264	CcSEcCtD
Alosetron—Urticaria—Chlorambucil—ovarian cancer	0.00183	0.00264	CcSEcCtD
Alosetron—Myalgia—Vinorelbine—ovarian cancer	0.00183	0.00264	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00183	0.00264	CcSEcCtD
Alosetron—Bone pain—Doxorubicin—ovarian cancer	0.00183	0.00264	CcSEcCtD
Alosetron—Cystitis—Epirubicin—ovarian cancer	0.00183	0.00263	CcSEcCtD
Alosetron—Nasopharyngitis—Docetaxel—ovarian cancer	0.00182	0.00263	CcSEcCtD
Alosetron—Colitis—Epirubicin—ovarian cancer	0.00182	0.00262	CcSEcCtD
Alosetron—Discomfort—Vinorelbine—ovarian cancer	0.00181	0.00261	CcSEcCtD
Alosetron—Urinary tract infection—Paclitaxel—ovarian cancer	0.0018	0.0026	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.0018	0.00259	CcSEcCtD
Alosetron—Fatigue—Topotecan—ovarian cancer	0.00177	0.00255	CcSEcCtD
Alosetron—Pain—Topotecan—ovarian cancer	0.00176	0.00253	CcSEcCtD
Alosetron—Constipation—Topotecan—ovarian cancer	0.00176	0.00253	CcSEcCtD
Alosetron—Infection—Vinorelbine—ovarian cancer	0.00175	0.00252	CcSEcCtD
Alosetron—Sinusitis—Paclitaxel—ovarian cancer	0.00174	0.0025	CcSEcCtD
Alosetron—Fatigue—Melphalan—ovarian cancer	0.00174	0.0025	CcSEcCtD
Alosetron—Abnormal dreams—Doxorubicin—ovarian cancer	0.00173	0.0025	CcSEcCtD
Alosetron—Pain—Melphalan—ovarian cancer	0.00172	0.00248	CcSEcCtD
Alosetron—Bladder pain—Epirubicin—ovarian cancer	0.00171	0.00247	CcSEcCtD
Alosetron—Cystitis noninfective—Doxorubicin—ovarian cancer	0.00171	0.00247	CcSEcCtD
Alosetron—Skin disorder—Vinorelbine—ovarian cancer	0.00171	0.00246	CcSEcCtD
Alosetron—Hypersensitivity—Chlorambucil—ovarian cancer	0.0017	0.00245	CcSEcCtD
Alosetron—Feeling abnormal—Topotecan—ovarian cancer	0.00169	0.00244	CcSEcCtD
Alosetron—Cystitis—Doxorubicin—ovarian cancer	0.00169	0.00244	CcSEcCtD
Alosetron—Colitis—Doxorubicin—ovarian cancer	0.00168	0.00242	CcSEcCtD
Alosetron—Haemoglobin—Paclitaxel—ovarian cancer	0.00167	0.00241	CcSEcCtD
Alosetron—Haemorrhage—Paclitaxel—ovarian cancer	0.00167	0.0024	CcSEcCtD
Alosetron—Asthenia—Chlorambucil—ovarian cancer	0.00166	0.00239	CcSEcCtD
Alosetron—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00166	0.00238	CcSEcCtD
Alosetron—Urticaria—Topotecan—ovarian cancer	0.00163	0.00235	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.0016	0.00231	CcSEcCtD
Alosetron—Urticaria—Melphalan—ovarian cancer	0.0016	0.0023	CcSEcCtD
Alosetron—Bladder pain—Doxorubicin—ovarian cancer	0.00159	0.00228	CcSEcCtD
Alosetron—Jaundice—Docetaxel—ovarian cancer	0.00153	0.00221	CcSEcCtD
Alosetron—Eczema—Epirubicin—ovarian cancer	0.00153	0.0022	CcSEcCtD
Alosetron—Fatigue—Vinorelbine—ovarian cancer	0.00152	0.00218	CcSEcCtD
Alosetron—Hypersensitivity—Topotecan—ovarian cancer	0.00151	0.00218	CcSEcCtD
Alosetron—Pain—Vinorelbine—ovarian cancer	0.0015	0.00216	CcSEcCtD
Alosetron—Constipation—Vinorelbine—ovarian cancer	0.0015	0.00216	CcSEcCtD
Alosetron—Arrhythmia—Paclitaxel—ovarian cancer	0.00149	0.00214	CcSEcCtD
Alosetron—Hypersensitivity—Melphalan—ovarian cancer	0.00148	0.00214	CcSEcCtD
Alosetron—Asthenia—Topotecan—ovarian cancer	0.00148	0.00212	CcSEcCtD
Alosetron—Alopecia—Paclitaxel—ovarian cancer	0.00147	0.00212	CcSEcCtD
Alosetron—Vomiting—Chlorambucil—ovarian cancer	0.00147	0.00211	CcSEcCtD
Alosetron—Feeling abnormal—Vinorelbine—ovarian cancer	0.00145	0.00209	CcSEcCtD
Alosetron—Asthenia—Melphalan—ovarian cancer	0.00144	0.00208	CcSEcCtD
Alosetron—Flatulence—Paclitaxel—ovarian cancer	0.00143	0.00206	CcSEcCtD
Alosetron—Haemoglobin—Docetaxel—ovarian cancer	0.00142	0.00204	CcSEcCtD
Alosetron—Eczema—Doxorubicin—ovarian cancer	0.00142	0.00204	CcSEcCtD
Alosetron—Hepatitis—Docetaxel—ovarian cancer	0.00141	0.00203	CcSEcCtD
Alosetron—Haemorrhage—Docetaxel—ovarian cancer	0.00141	0.00203	CcSEcCtD
Alosetron—Hypoglycaemia—Epirubicin—ovarian cancer	0.00141	0.00203	CcSEcCtD
Alosetron—Hypoaesthesia—Docetaxel—ovarian cancer	0.0014	0.00202	CcSEcCtD
Alosetron—Urticaria—Vinorelbine—ovarian cancer	0.0014	0.00201	CcSEcCtD
Alosetron—Muscle spasms—Paclitaxel—ovarian cancer	0.00139	0.00201	CcSEcCtD
Alosetron—Nausea—Chlorambucil—ovarian cancer	0.00137	0.00197	CcSEcCtD
Alosetron—Tremor—Paclitaxel—ovarian cancer	0.00136	0.00195	CcSEcCtD
Alosetron—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00134	0.00194	CcSEcCtD
Alosetron—Vomiting—Topotecan—ovarian cancer	0.00131	0.00188	CcSEcCtD
Alosetron—Malaise—Paclitaxel—ovarian cancer	0.00131	0.00188	CcSEcCtD
Alosetron—Hypoglycaemia—Doxorubicin—ovarian cancer	0.0013	0.00188	CcSEcCtD
Alosetron—Rash—Topotecan—ovarian cancer	0.0013	0.00187	CcSEcCtD
Alosetron—Hypersensitivity—Vinorelbine—ovarian cancer	0.0013	0.00187	CcSEcCtD
Alosetron—Dermatitis—Topotecan—ovarian cancer	0.0013	0.00186	CcSEcCtD
Alosetron—Headache—Topotecan—ovarian cancer	0.00129	0.00185	CcSEcCtD
Alosetron—Vomiting—Melphalan—ovarian cancer	0.00128	0.00184	CcSEcCtD
Alosetron—Rash—Melphalan—ovarian cancer	0.00127	0.00183	CcSEcCtD
Alosetron—Dermatitis—Melphalan—ovarian cancer	0.00127	0.00183	CcSEcCtD
Alosetron—Cough—Paclitaxel—ovarian cancer	0.00126	0.00182	CcSEcCtD
Alosetron—Asthenia—Vinorelbine—ovarian cancer	0.00126	0.00182	CcSEcCtD
Alosetron—Arrhythmia—Docetaxel—ovarian cancer	0.00126	0.00181	CcSEcCtD
Alosetron—Abdominal pain upper—Epirubicin—ovarian cancer	0.00126	0.00181	CcSEcCtD
Alosetron—Hypertension—Paclitaxel—ovarian cancer	0.00125	0.0018	CcSEcCtD
Alosetron—Alopecia—Docetaxel—ovarian cancer	0.00125	0.0018	CcSEcCtD
Alosetron—Myalgia—Paclitaxel—ovarian cancer	0.00123	0.00178	CcSEcCtD
Alosetron—Nasopharyngitis—Epirubicin—ovarian cancer	0.00123	0.00177	CcSEcCtD
Alosetron—Anxiety—Paclitaxel—ovarian cancer	0.00123	0.00177	CcSEcCtD
Alosetron—Nausea—Topotecan—ovarian cancer	0.00122	0.00176	CcSEcCtD
Alosetron—Discomfort—Paclitaxel—ovarian cancer	0.00122	0.00176	CcSEcCtD
Alosetron—Gastritis—Epirubicin—ovarian cancer	0.00122	0.00175	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00121	0.00175	CcSEcCtD
Alosetron—Dry mouth—Paclitaxel—ovarian cancer	0.00121	0.00174	CcSEcCtD
Alosetron—Abdominal distension—Epirubicin—ovarian cancer	0.0012	0.00172	CcSEcCtD
Alosetron—Nausea—Melphalan—ovarian cancer	0.0012	0.00172	CcSEcCtD
Alosetron—Confusional state—Paclitaxel—ovarian cancer	0.00119	0.00172	CcSEcCtD
Alosetron—Muscle spasms—Docetaxel—ovarian cancer	0.00118	0.0017	CcSEcCtD
Alosetron—Infection—Paclitaxel—ovarian cancer	0.00118	0.00169	CcSEcCtD
Alosetron—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00116	0.00167	CcSEcCtD
Alosetron—Skin disorder—Paclitaxel—ovarian cancer	0.00115	0.00165	CcSEcCtD
Alosetron—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00114	0.00165	CcSEcCtD
Alosetron—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00114	0.00164	CcSEcCtD
Alosetron—Gastritis—Doxorubicin—ovarian cancer	0.00113	0.00162	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.00112	0.00162	CcSEcCtD
Alosetron—Vomiting—Vinorelbine—ovarian cancer	0.00112	0.00161	CcSEcCtD
Alosetron—Rash—Vinorelbine—ovarian cancer	0.00111	0.0016	CcSEcCtD
Alosetron—Dermatitis—Vinorelbine—ovarian cancer	0.00111	0.00159	CcSEcCtD
Alosetron—Abdominal distension—Doxorubicin—ovarian cancer	0.00111	0.00159	CcSEcCtD
Alosetron—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00111	0.00159	CcSEcCtD
Alosetron—Headache—Vinorelbine—ovarian cancer	0.0011	0.00159	CcSEcCtD
Alosetron—Pollakiuria—Epirubicin—ovarian cancer	0.0011	0.00158	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00108	0.00155	CcSEcCtD
Alosetron—Hyperglycaemia—Epirubicin—ovarian cancer	0.00107	0.00154	CcSEcCtD
Alosetron—Cough—Docetaxel—ovarian cancer	0.00107	0.00154	CcSEcCtD
Alosetron—Hypertension—Docetaxel—ovarian cancer	0.00106	0.00153	CcSEcCtD
Alosetron—Myalgia—Docetaxel—ovarian cancer	0.00105	0.00151	CcSEcCtD
Alosetron—Nausea—Vinorelbine—ovarian cancer	0.00104	0.0015	CcSEcCtD
Alosetron—Jaundice—Epirubicin—ovarian cancer	0.00103	0.00149	CcSEcCtD
Alosetron—Urinary tract infection—Epirubicin—ovarian cancer	0.00103	0.00148	CcSEcCtD
Alosetron—Dry mouth—Docetaxel—ovarian cancer	0.00102	0.00147	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00102	0.00147	CcSEcCtD
Alosetron—Fatigue—Paclitaxel—ovarian cancer	0.00102	0.00147	CcSEcCtD
Alosetron—Sweating—Epirubicin—ovarian cancer	0.00102	0.00146	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—ovarian cancer	0.00102	0.00146	CcSEcCtD
Alosetron—Constipation—Paclitaxel—ovarian cancer	0.00101	0.00146	CcSEcCtD
Alosetron—Pain—Paclitaxel—ovarian cancer	0.00101	0.00146	CcSEcCtD
Alosetron—Confusional state—Docetaxel—ovarian cancer	0.00101	0.00146	CcSEcCtD
Alosetron—Infection—Docetaxel—ovarian cancer	0.000996	0.00143	CcSEcCtD
Alosetron—Sinusitis—Epirubicin—ovarian cancer	0.000995	0.00143	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000993	0.00143	CcSEcCtD
Alosetron—Feeling abnormal—Paclitaxel—ovarian cancer	0.000975	0.0014	CcSEcCtD
Alosetron—Skin disorder—Docetaxel—ovarian cancer	0.000974	0.0014	CcSEcCtD
Alosetron—Haemoglobin—Epirubicin—ovarian cancer	0.000957	0.00138	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—ovarian cancer	0.000956	0.00138	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—ovarian cancer	0.000954	0.00137	CcSEcCtD
Alosetron—Haemorrhage—Epirubicin—ovarian cancer	0.000952	0.00137	CcSEcCtD
Alosetron—Hepatitis—Epirubicin—ovarian cancer	0.000952	0.00137	CcSEcCtD
Alosetron—Hypoaesthesia—Epirubicin—ovarian cancer	0.000947	0.00136	CcSEcCtD
Alosetron—Sweating—Doxorubicin—ovarian cancer	0.000941	0.00135	CcSEcCtD
Alosetron—Urticaria—Paclitaxel—ovarian cancer	0.00094	0.00135	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—ovarian cancer	0.000921	0.00133	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000914	0.00132	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—ovarian cancer	0.000885	0.00127	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—ovarian cancer	0.000881	0.00127	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—ovarian cancer	0.000881	0.00127	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000876	0.00126	CcSEcCtD
Alosetron—Hypersensitivity—Paclitaxel—ovarian cancer	0.000872	0.00125	CcSEcCtD
Alosetron—Fatigue—Docetaxel—ovarian cancer	0.000864	0.00124	CcSEcCtD
Alosetron—Pain—Docetaxel—ovarian cancer	0.000857	0.00123	CcSEcCtD
Alosetron—Constipation—Docetaxel—ovarian cancer	0.000857	0.00123	CcSEcCtD
Alosetron—Arrhythmia—Epirubicin—ovarian cancer	0.00085	0.00122	CcSEcCtD
Alosetron—Asthenia—Paclitaxel—ovarian cancer	0.000849	0.00122	CcSEcCtD
Alosetron—Alopecia—Epirubicin—ovarian cancer	0.000841	0.00121	CcSEcCtD
Alosetron—Feeling abnormal—Docetaxel—ovarian cancer	0.000826	0.00119	CcSEcCtD
Alosetron—Flatulence—Epirubicin—ovarian cancer	0.000817	0.00118	CcSEcCtD
Alosetron—Muscle spasms—Epirubicin—ovarian cancer	0.000797	0.00115	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—ovarian cancer	0.000787	0.00113	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—ovarian cancer	0.000778	0.00112	CcSEcCtD
Alosetron—Ill-defined disorder—Epirubicin—ovarian cancer	0.000769	0.00111	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—ovarian cancer	0.000756	0.00109	CcSEcCtD
Alosetron—Vomiting—Paclitaxel—ovarian cancer	0.000752	0.00108	CcSEcCtD
Alosetron—Malaise—Epirubicin—ovarian cancer	0.000747	0.00108	CcSEcCtD
Alosetron—Rash—Paclitaxel—ovarian cancer	0.000746	0.00107	CcSEcCtD
Alosetron—Dermatitis—Paclitaxel—ovarian cancer	0.000745	0.00107	CcSEcCtD
Alosetron—Headache—Paclitaxel—ovarian cancer	0.000741	0.00107	CcSEcCtD
Alosetron—Hypersensitivity—Docetaxel—ovarian cancer	0.000739	0.00106	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—ovarian cancer	0.000737	0.00106	CcSEcCtD
Alosetron—Cough—Epirubicin—ovarian cancer	0.000723	0.00104	CcSEcCtD
Alosetron—Asthenia—Docetaxel—ovarian cancer	0.000719	0.00104	CcSEcCtD
Alosetron—Hypertension—Epirubicin—ovarian cancer	0.000715	0.00103	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000711	0.00102	CcSEcCtD
Alosetron—Myalgia—Epirubicin—ovarian cancer	0.000705	0.00102	CcSEcCtD
Alosetron—Anxiety—Epirubicin—ovarian cancer	0.000703	0.00101	CcSEcCtD
Alosetron—Nausea—Paclitaxel—ovarian cancer	0.000703	0.00101	CcSEcCtD
Alosetron—Discomfort—Epirubicin—ovarian cancer	0.000697	0.001	CcSEcCtD
Alosetron—Malaise—Doxorubicin—ovarian cancer	0.000691	0.000995	CcSEcCtD
Alosetron—Dry mouth—Epirubicin—ovarian cancer	0.00069	0.000993	CcSEcCtD
Alosetron—Confusional state—Epirubicin—ovarian cancer	0.000682	0.000982	CcSEcCtD
Alosetron—Infection—Epirubicin—ovarian cancer	0.000672	0.000967	CcSEcCtD
Alosetron—Cough—Doxorubicin—ovarian cancer	0.000669	0.000963	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—ovarian cancer	0.000662	0.000953	CcSEcCtD
Alosetron—Skin disorder—Epirubicin—ovarian cancer	0.000657	0.000946	CcSEcCtD
Alosetron—Hyperhidrosis—Epirubicin—ovarian cancer	0.000654	0.000941	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—ovarian cancer	0.000653	0.00094	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—ovarian cancer	0.000651	0.000936	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—ovarian cancer	0.000645	0.000928	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—ovarian cancer	0.000638	0.000919	CcSEcCtD
Alosetron—Vomiting—Docetaxel—ovarian cancer	0.000638	0.000918	CcSEcCtD
Alosetron—Rash—Docetaxel—ovarian cancer	0.000632	0.00091	CcSEcCtD
Alosetron—Dermatitis—Docetaxel—ovarian cancer	0.000632	0.000909	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—ovarian cancer	0.000631	0.000908	CcSEcCtD
Alosetron—Headache—Docetaxel—ovarian cancer	0.000628	0.000904	CcSEcCtD
Alosetron—Infection—Doxorubicin—ovarian cancer	0.000622	0.000895	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000616	0.000887	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—ovarian cancer	0.000608	0.000875	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000605	0.000871	CcSEcCtD
Alosetron—Nausea—Docetaxel—ovarian cancer	0.000596	0.000857	CcSEcCtD
Alosetron—Fatigue—Epirubicin—ovarian cancer	0.000583	0.000839	CcSEcCtD
Alosetron—Pain—Epirubicin—ovarian cancer	0.000578	0.000833	CcSEcCtD
Alosetron—Constipation—Epirubicin—ovarian cancer	0.000578	0.000833	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00057	0.000821	CcSEcCtD
Alosetron—Feeling abnormal—Epirubicin—ovarian cancer	0.000557	0.000802	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—ovarian cancer	0.00054	0.000777	CcSEcCtD
Alosetron—Urticaria—Epirubicin—ovarian cancer	0.000537	0.000773	CcSEcCtD
Alosetron—Pain—Doxorubicin—ovarian cancer	0.000535	0.00077	CcSEcCtD
Alosetron—Constipation—Doxorubicin—ovarian cancer	0.000535	0.00077	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—ovarian cancer	0.000516	0.000742	CcSEcCtD
Alosetron—Hypersensitivity—Epirubicin—ovarian cancer	0.000498	0.000717	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—ovarian cancer	0.000497	0.000716	CcSEcCtD
Alosetron—Asthenia—Epirubicin—ovarian cancer	0.000485	0.000698	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—ovarian cancer	0.000461	0.000664	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—ovarian cancer	0.000449	0.000646	CcSEcCtD
Alosetron—Vomiting—Epirubicin—ovarian cancer	0.00043	0.000619	CcSEcCtD
Alosetron—Rash—Epirubicin—ovarian cancer	0.000426	0.000614	CcSEcCtD
Alosetron—Dermatitis—Epirubicin—ovarian cancer	0.000426	0.000613	CcSEcCtD
Alosetron—Headache—Epirubicin—ovarian cancer	0.000424	0.00061	CcSEcCtD
Alosetron—Nausea—Epirubicin—ovarian cancer	0.000402	0.000578	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—ovarian cancer	0.000398	0.000573	CcSEcCtD
Alosetron—Rash—Doxorubicin—ovarian cancer	0.000395	0.000568	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—ovarian cancer	0.000394	0.000567	CcSEcCtD
Alosetron—Headache—Doxorubicin—ovarian cancer	0.000392	0.000564	CcSEcCtD
Alosetron—Nausea—Doxorubicin—ovarian cancer	0.000372	0.000535	CcSEcCtD
